InnoCare Pharma (688428.SS) Stock Price
InnoCare Pharma Price
Over the last 5 years InnoCare Pharma grew revenue by 344.8% annually, reaching 2.37 B CNY. For InnoCare Pharma, the net margin of 27.1% is up versus -6.2% a few years ago. The consensus 12-month price target for InnoCare Pharma is 35.70 CNY, about 32.5% above where the stock trades today. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus.
InnoCare Pharma stock price
InnoCare Pharma business model & stock analysis
Frequently asked questions about InnoCare Pharma
Analysts currently set an average price target of 39.54 CNY for the InnoCare Pharma stock (median: 35.70 CNY), implying +46.7 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the InnoCare Pharma stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect InnoCare Pharma to generate revenue of 2.46 B CNY and earnings per share of 0.16 CNY.
Converted at the current exchange rate, the InnoCare Pharma share trades at 3.60 EUR (26.95 CNY).
The expected revenue of InnoCare Pharma is 2.46 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of InnoCare Pharma is 281.95 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of InnoCare Pharma is currently 168.32. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the InnoCare Pharma stock.
The price-to-sales ratio (P/S) of InnoCare Pharma is currently 19.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the InnoCare Pharma stock.
The Eulerpool Quality Score for InnoCare Pharma is 4/10.
The ISIN of InnoCare Pharma is CNE100005P56. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of InnoCare Pharma is 688428.SS. The ticker symbol is used to trade InnoCare Pharma shares on the stock exchange.
InnoCare Pharma stock
InnoCare Pharma Peer Group
InnoCare Pharma FIGI
All fundamentals and in-depth analysis of InnoCare Pharma
Our stock analysis for InnoCare Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InnoCare Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.